Brief: PAION completes patient recruitment in U.S. clinical safety trial of remimazolam

PAION AG

20/12/2016 06:31

Dec 20(Reuters) - PAION AG  PA8G.DE : 
    * Announced on Monday successful completion of patient 
recruitment in U.S. clinical safety trial of remimazolam in 
high-risk patients undergoing colonoscopy 
    * Said no drug-related serious adverse events have been 
reported 
    * Headline data expected in the first half of 2017 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nEQFjLHn 
     
 Further company coverage:  PA8G.DE   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))